NCT06311357 is a NA clinical trial of Ensure in Early Stage Breast Cancer, sponsored by Department of Medical Services Ministry of Public Health of Thailand.

Who is sponsoring NCT06311357?

NCT06311357 is sponsored by Department of Medical Services Ministry of Public Health of Thailand.

What drugs are being tested in NCT06311357?

Interventions in NCT06311357: Ensure.

What condition does NCT06311357 study?

NCT06311357 studies Early Stage Breast Cancer.

Is NCT06311357 still recruiting?

NCT06311357 is currently status unknown. Last updated 27 December 2024.

Last reviewed 2024-12-27 · How we verify

NCT06311357

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Percent Weight Change in the Medical Supplement Group of Early Breast Cancer

Status unknown NA Last updated 27 December 2024

What this trial tests

NA trial testing Ensure in Early Stage Breast Cancer in 40 participants. Status unknown.

Timeline

12 July 2023

Primary endpoint
26 April 2024

30 December 2024

Quick facts

Lead sponsor	Department of Medical Services Ministry of Public Health of Thailand
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	supportive care
Enrollment	40
Start date	12 July 2023
Primary completion	26 April 2024
Estimated completion	30 December 2024
Sites	1 location across Thailand

Drugs / interventions tested

Ensure

Conditions studied

Early Stage Breast Cancer — all drugs for Early Stage Breast Cancer →

Sponsor

Department of Medical Services Ministry of Public Health of Thailand

Who can join

Adults 18 to 80, female only, with Early Stage Breast Cancer. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this RCT is to compare percent weight change in early breast cancer who takes medical supplement or not, during treatment with chemotherapy (standard AC regimen). The main question is • the change of weight (%) before and after complete treatment of breast cancer therapy. Participants will be randomized into 2 group * intervention group - receive medical supplement daily during chemotherapy treatment. * control group - Nutritional advise during chemotherapy treatment.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Body weight change in a medical supplement group in patients with early breast cancer during chemotherapy: a randomized, controlled trial.
Tienchaiananda P, Juntong M, Pintasiri P, Sa-Nguansai S, et al · · 2025 · cited 1× · PMID 40106001 · DOI 10.1007/s00520-025-09359-z

Verify or expand the search:

Other trials of Ensure

Trials testing the same drug.

NCT04210284 — Oral Nutritional Optimization in Total Joint Arthroplasty · NA · recruiting
NCT04464161 — The Effects of Perioperative Nutritional Optimization on Blood Markers · NA · completed
NCT03470181 — Applying Nutrient Drink Test in Understanding Pathophysiology of CVS · completed
NCT02624752 — Oral Nutrition Supplementation in Hospitalized Patients · NA · completed

Other recruiting trials for Early Stage Breast Cancer

Currently open trials in the same condition.

NCT06768931 — Biolosion Combined Standard Neoadjuvant Therapy to Treat Triple-negative Breast Cancer · Phase 2 · recruiting
NCT07071038 — Evaluating the Use of a Medication 'Switch' vs Guideline-directed Interventions for Relieving Side Effects of Aromatase · Phase 2 · recruiting
NCT04458532 — Exercise Therapy to Improve Cardiovascular Health in Post-Menopausal Women After Treatment for Early Stage Breast Cancer · NA · recruiting
NCT03561454 — A Registry of Intra-Operative Radiation Therapy (IORT) Using the Xoft ® Axxent ® eBx ™ System Patients · active not recruiting

Other Department of Medical Services Ministry of Public Health of Thailand trials

Trials by the same sponsor.

NCT06665737 — Outcomes of Early and Late Administration G-CSF for Primary Prophylaxis in Non-Hodgkin's Lymphoma Patients · Phase 4 · not yet recruiting
NCT06763575 — Efficacy of Surgical Glove-Compression Therapy As a Prevention of Paclitaxel-Induced Peripheral Neuropathy · NA · recruiting
NCT06860659 — Efficacy of 0.28% Sodium Hyaluronate Eye Drops in Patient With Moderate to Severe Dry Eye · Phase 4 · enrolling by invitation
NCT06525870 — Efficacy of Topical 85% TCA in the Treatment of LSIL After Low-grade Abnormality of Screening Test: a Randomized Control · Phase 2 · enrolling by invitation
NCT06436833 — Comparison of Bowel Preparation Using 2 Liter Polyethylene Glycol Regimen Plus Elobixibat Versus 4-Liter Polyethylene Gl · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06311357 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Department of Medical Services Ministry of Public Health of Thailand
Last refreshed: 27 December 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06311357.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing